Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Collisson

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Plos One|October 17, 2015
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNARichard B Lanman, Stefanie A Mortimer, Oliver A Zill, et al.
Cancer Discovery|June 26, 2015
Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary CarcinomasOliver A Zill, Claire Greene, Dragan Sebisanovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2020
Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic CancerAnna Moroz, Yung-Hua Wang, Jeremy M Sharib, et al.
Nature Medicine|April 5, 2011
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapyEric A Collisson, Anguraj Sadanandam, Peter Olson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2015
A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic AdenocarcinomaAndrew H Ko, Tanios Bekaii-Saab, Jessica Van Ziffle, et al.
Cancer Letters|June 26, 2016
An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancerGayatri Premasekharan, Elizabeth Gilbert, Ross A Okimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2026
Efficacy of the ATR inhibitor ceralasertib in patients with ARID1A-deficient gynecologic and other solid tumor malignanciesXiaolin Zhu, Edwin A Alvarez, Sarah E Umetsu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 28, 2023
A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern AfricaKatherine Van Loon, Elia J Mmbaga, Beatrice P Mushi, et al.
Elife|May 19, 2021
Single-cell transcriptome analysis defines heterogeneity of the murine pancreatic ductal treeAudrey M Hendley, Arjun A Rao, Laura Leonhardt, et al.
JCO Precision Oncology|December 12, 2024
Phase II Study of Sunitinib in Tumors With <i>c-KIT</i> Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol VLilian T Gien, Zihe Song, Andrew Poklepovic, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Plos One|October 17, 2015
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNARichard B Lanman, Stefanie A Mortimer, Oliver A Zill, et al.
Cancer Discovery|June 26, 2015
Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary CarcinomasOliver A Zill, Claire Greene, Dragan Sebisanovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2020
Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic CancerAnna Moroz, Yung-Hua Wang, Jeremy M Sharib, et al.
Nature Medicine|April 5, 2011
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapyEric A Collisson, Anguraj Sadanandam, Peter Olson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2015
A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic AdenocarcinomaAndrew H Ko, Tanios Bekaii-Saab, Jessica Van Ziffle, et al.
Cancer Letters|June 26, 2016
An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancerGayatri Premasekharan, Elizabeth Gilbert, Ross A Okimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2026
Efficacy of the ATR inhibitor ceralasertib in patients with ARID1A-deficient gynecologic and other solid tumor malignanciesXiaolin Zhu, Edwin A Alvarez, Sarah E Umetsu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 28, 2023
A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern AfricaKatherine Van Loon, Elia J Mmbaga, Beatrice P Mushi, et al.
Elife|May 19, 2021
Single-cell transcriptome analysis defines heterogeneity of the murine pancreatic ductal treeAudrey M Hendley, Arjun A Rao, Laura Leonhardt, et al.
JCO Precision Oncology|December 12, 2024
Phase II Study of Sunitinib in Tumors With <i>c-KIT</i> Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol VLilian T Gien, Zihe Song, Andrew Poklepovic, et al.
Pageof 10